Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.730
+0.015 (0.55%)
Sep 22, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 182.19 million as of September 22, 2026. Its market cap has decreased by -24.47% in one year.
Market Cap
182.19M
Enterprise Value
124.06M
Revenue
7.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.73
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 182.19M, an increase of 48.55%. That is a compound annual growth rate of 7.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 182.19M | -28.09% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 311.27M |
| IRLAB Therapeutics AB | 256.68M |
| Isofol Medical AB | 237.16M |
| Xbrane Biopharma AB | 208.11M |
| Abera Bioscience AB | 161.94M |
| Simris Group AB (PUBL) | 158.60M |
| Diamyd Medical AB | 156.53M |
| Initiator Pharma | 144.44M |